文章摘要
孟昭伟,秦明照.衰弱对老年心房颤动合并共病抗凝治疗的影响[J].中国临床保健杂志,2023,26(1):41-45.
衰弱对老年心房颤动合并共病抗凝治疗的影响
Effect of frailty on anticoagulants in comorbidity combined with atrial fibrillation in the elderly
投稿时间:2022-08-22  
DOI:10.3969/J.issn.1672-6790.2023.01.009
中文关键词: 衰弱  抗凝药  心房颤动  慢性病共病  老年人  综述
英文关键词: Frailty  Anticoagulants  Atrial fibrillation  Multiple chronic conditions  Aged  Review 〖FL
基金项目:
作者单位E-mail
孟昭伟 首都医科大学研究生院,北京 100069 qinmingzhao58@163.com 
秦明照 首都医科大学附属北京同仁医院老年科 qinmingzhao58@163.com 
摘要点击次数: 1048
全文下载次数: 2089
中文摘要:
      随着人口老龄化加剧,老年心房颤动合并共病的情况越来越常见,老年心房颤动合并共病患者容易发生衰弱,衰弱可以对心房颤动患者产生不利影响。而国内外指南缺少针对衰弱的老年心房颤动患者抗凝的具体管理建议。老年心房颤动合并共病患者抗凝除应进行出血及栓塞风险评估外,也需完善有关衰弱的老年综合评估。衰弱的老年心房颤动合并共病患者应该接受合理的抗凝治疗,新型口服抗凝药是其首选推荐。
英文摘要:
      With the aging of the population,the number of comorbidity combined with atrial fibrillation(AF) in the elderly continues to increase.Elderly patients with comorbidity combined with AF are prone to frailty,which can adversely affect AF patients.However,domestic and foreign guidelines lack specific management suggestions for anticoagulation in frailty elderly patients with AF.In addition to the risk assessment of bleeding and embolization in elderly patients with comorbidity and AF,the comprehensive geriatric assessment of frailty should also be improved.Frailty elderly patients with comorbidities with AF should be adequately anticoagulant treated,and new oral anticoagulants are their preferred recommendation.
查看全文     
关闭
分享按钮